Articles tagged with 'Prevention' & 'Cancer' | Cedars-Sinai Medical Center

With the holiday season underway, and families and friends gathering to celebrate, a leading Cedars-Sinai Guerin Children’s pediatrician has one word of advice for parents: Vaccinate.Shervin Rabizadeh, MD, chair of Pediatrics at Cedars-Sinai Guerin C...

As the number of sexually transmitted infections (STIs) sharply rises in the U.S., new evidence suggests that a common antibiotic—doxycycline—could help prevent the spread of some bacterial infections. Based on results from new clinical trials, the C...

Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status. Their study, published today i...

Huntington Health recently marked the two-year anniversary of its affiliation with Cedars-Sinai Health System. In this brief time, the relationship has brought important benefits to both organizations, their staffs and the patients they serve.Hunting...

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard treatment. The results ...

Amanda Butler and Isabella Bugatti, both just entering their 30s, were blindsided by a diagnosis that is on the rise among women their age: breast cancer.They are not the only ones. A recent study in the peer-reviewed journal JAMA Network Open found ...

Hematologist-oncologist Navid Hafez, MD, MPH, has joined The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, as director of Precision Medicine and Thoracic Oncology. Hafez will focus on clinical research programs to develo...

Hematologist/oncologist Kevin Scher, MD, MBA, an expert in patient-centric care with more than 10 years of experience on the Cedars-Sinai Cancer faculty, has been appointed medical director of Cedars-Sinai Cancer in Beverly Hills. In his new role, Sc...

Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the peer-review...

Investigators from Cedars-Sinai Cancer found that Black women with a low-risk form of endometrial cancer were less likely than white women with the same cancer to have a hysterectomy, and less likely to survive their cancer. The study, published in t...

Investigators from The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, have determined that a combination of drugs that act on the immune system in distinct ways improves survival for patients with the deadliest form of sk...

Cedars-Sinai Cancer investigators are spearheading a project, funded by a five-year, $11.2 million grant from the National Cancer Institute, part of the National Institutes of Health, to advance scientific knowledge of how biological differences betw...

Niki Patel, MD, a fellowship-trained hematologist-oncologist board certified in internal medicine and medical oncology, has joined the Division of Medical Oncology at Cedars-Sinai Cancer. She is treating patients in Pasadena at Huntington Cancer Cent...

Gynecologic oncologist Margaret Liang, MD, has joined the Cedars-Sinai Cancer Division of Gynecologic Oncology, providing care and clinical services for patients within the Department of Obstetrics and Gynecology. She also joins as director for the G...

New research from Cedars-Sinai Cancer investigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common cause of hereditary colorectal and endometrial cancers. Their st...

It’s summertime and California hiking trails are beckoning. But along with lusher than usual greenery due to this year’s heavy rains, the hills are alive with ticks and fleas. The Cedars-Sinai Newsroom talked with Priya Soni, MD, a pediatric infectio...

Members of the Los Angeles Rams’ 2023 rookie class visited Cedars-Sinai this week, bringing smiles to patients throughout the medical center and Cedars-Sinai Marina del Rey Hospital.The football players visited pediatric patients in Guerin Children’s...

Leo Mascarenhas, MD, MS, an internationally recognized pediatric hematologist-oncologist and sarcoma expert, has been appointed director of Pediatric Hematology and Oncology at Cedars-Sinai Guerin Children’s and as medical director of the Sarcoma Pro...

As men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body’s ability to fight cancer, according to new research from Cedars-Sinai Cancer.The study, published today in the leadi...

Physicians at Cedars-Sinai Cancer are using a unique chemotherapy delivery system that offers hope to colorectal cancer patients whose disease has spread and who now have inoperable liver tumors. Cedars-Sinai is one of the few centers in the area to ...

Carlos Rene Valdez is a big fan of the saying “dance like no one’s watching,” but with one modification. An overachiever with a healthy dose of confidence, Valdez enjoys dancing like no one’s watching even when everyone is watching.Valdez’s dance thr...

Investigators from Cedars-Sinai Cancer, working in collaboration with colleagues in Colorado and the Netherlands, have identified a specific type of bladder cancer most likely to resist first-line treatment. Their study, published today in the peer-r...

Investigators at Cedars-Sinai Cancer found that fatty liver, a condition closely associated with obesity, promotes the spread of colorectal cancer to the liver. Their study, published today in the peer-reviewed journal Cell Metabolism, details the pr...

Cedars-Sinai Cancer welcomes Karine Sargsyan, MD, formerly director of one of the world’s largest clinical biobanks, as scientific director of its OncoBiobank. Sargsyan is charged with leading biobank development and creating new strategies for the o...

Research from Cedars-Sinai Cancer detailing the largest examination to date of prostate cancer in transgender women, as well as treatment options that improve outcomes in patients with recurrent prostate cancer, will be presented during the American ...

Vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men, new research from Cedars-Sinai Cancer suggests. The multi-institutional study, published to...

Cedars-Sinai Cancer’s commitment to convergent science—the deep melding of computational, physical engineering and biological sciences—is evident throughout its 2023 Annual Report. The newly released report highlights clinical and research experts fr...

Investigators from Cedars-Sinai Cancer are collaborating on a streamlined clinical trial design in a study called Pragmatica-Lung. This randomized Phase III trial funded by the National Cancer Institute (NCI), part of the National Institutes of Healt...

A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge,...

Cedars-Sinai has received a gift of more than $140 million—the largest gift in the hospital’s 121-year history—from the estate of longtime supporters Susanne and Ervin Bard. This gift will propel clinical and research innovation in the medical campus...